CNA trades 13.1% above Wall Street's consensus target of $45.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CNA achieves its forward estimates and maintains a stable P/E multiple of 12.9x. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, CNA Financial Corporation (CNA) has a Wall Street consensus price target of $45.00, based on estimates from 7 covering analysts. With the stock currently trading at $51.80, this represents a potential downside of -13.1%. The company has a market capitalization of $14.01B.
Analyst price targets range from a low of $45.00 to a high of $45.00, representing a 0% spread in expectations. The median target of $45.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 1 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CNA trades at a trailing P/E of 11.0x and forward P/E of 12.9x. The forward PEG ratio of 0.98 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -17.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $53.60, with bear and bull scenarios of $33.77 and $70.63 respectively. Model confidence stands at 44/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
TRVThe Travelers Companies, Inc. | $73.1B | $343.73 | $310.40 | -9.7% | Hold | 12.2x | 43 |
HIGThe Hartford Financial Services Group, Inc. | $38.4B | $139.64 | $150.38 | +7.7% | Buy | 10.9x | 42 |
CBChubb Limited | $139.4B | $359.30 | $346.75 | -3.5% | Buy | 13.3x | 43 |
WRBW. R. Berkley Corporation | $26.6B | $71.54 | $69.10 | -3.4% | Hold | 15.3x | 30 |
MKLMarkel Corporation | $24.6B | $1969.34 | $1950.00 | -1.0% | Hold | 18.5x | 15 |
CINFCincinnati Financial Corporation | $29.4B | $189.06 | $182.50 | -3.5% | Buy | 21.8x | 17 |
AIGAmerican International Group, Inc. | $43.5B | $81.06 | $84.17 | +3.8% | Hold | 10.0x | 41 |
ACGLArch Capital Group Ltd. | $35.9B | $102.85 | $102.57 | -0.3% | Buy | 11.1x | 34 |
RNRRenaissanceRe Holdings Ltd. | $14.0B | $323.69 | $310.75 | -4.0% | Hold | 7.9x | 28 |
SKWDSkyward Specialty Insurance Group, Inc. | $2.5B | $62.41 | $67.33 | +7.9% | Buy | 12.7x | 11 |
Quick answers to the most common questions about buying CNA stock.
CNA's consensus price target is $45, -13.1% below the current price of $51.8. The 7 analysts tracking CNA see downside risk at present valuations.
CNA has a consensus rating of "Hold" based on 7 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $45 implies -13.1% downside from current levels.
With a forward P/E of 12.8696x, CNA trades at a relatively low valuation. The consensus target of $45 implies -13.1% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $45 for CNA, while the most conservative target is $45. The consensus of $45 represents the median expectation. Our quantitative valuation model projects a bull case target of $71 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CNA is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 4 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CNA stock forecast based on 7 Wall Street analysts shows a consensus price target of $45, with estimates ranging from $45 (bear case) to $45 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $54, with bear/bull scenarios of $34/$71.
Our quantitative valuation model calculates CNA's fair value at $54 (base case), with a bear case of $34 and bull case of $71. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 44/100.
CNA trades at a forward P/E ratio of 12.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 11.0x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on CNA, with 1 Sell ratings and a price target of $45 (-13.1% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CNA analyst price targets range from $45 to $45, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $45 consensus represents the middle ground. Our model's $34-$71 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.